The Ang II treatment increased tubular atrophy and renal fibrosis in both groups of mice, and Ang II-treated Clu-/- mice exhibited significantly higher levels of renal tubulointerstitial damage and fibrosis than Ang II-treated wild-type mice (Fig. 1A). The gene discussed is CLU; the disease is renal fibrosis.